从$阿里那制药(ARNA)$ 分拆出来的小型biotech。（ARNA此前被辉瑞收购）

CNS领域催化剂来了，$Longboard(LBPH)$ 股价大涨。

Longboard Pharmaceuticals Announces Positive Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial, for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)